Details for the presentations are as follows: Title: AXS-05 (Auvelity®) in Major Depressive Disorder: Pooled Data from Two Six-Week Controlled Trials (GEMINI and ASCEND) Presentation Date and Time: ...
Axis Capital Holdings (NYSE:AXS) is scheduled to announce Q3 earnings results on Wednesday, October 30th, after market close. The consensus EPS Estimate is $2.54 (+8.5% Y/Y) and the consensus Revenue ...